Jill M. Quigley

Insider Reports History

Entity
Individual
Location
Two Commerce Square, 2001 Market Street, 28 Th Floor, Philadelphia, PA
Signature
/s/ David Strauss as Attorney-in-Fact for Jill M. Quigley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jill M. Quigley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Passage BIO, Inc. Chief Operating Officer Common Stock 369K $336K $0.91 Dec 8, 2021 Direct
Terns Pharmaceuticals, Inc. Director Common Stock 15K $150K $10.00 Sep 9, 2024 Direct
Passage BIO, Inc. Chief Operating Officer Common Stock 3.61K $3.28K $0.91 Dec 8, 2021 By Spouse
Passage BIO, Inc. Chief Operating Officer Employee Stock Option (right to buy) 27.6K Dec 8, 2021 Direct
Chemomab Therapeutics Ltd. Director Option to Purchase American Depositary Shares 13.6K Jun 16, 2022 Direct
Terns Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 Sep 9, 2024 Direct

Insider Reports Filed by Jill M. Quigley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TERN Terns Pharmaceuticals, Inc. Sep 9, 2024 3 -$141K 4 Sep 11, 2024 Director
TERN Terns Pharmaceuticals, Inc. Aug 1, 2024 2 -$114K 4 Aug 5, 2024 Director
TERN Terns Pharmaceuticals, Inc. Jul 15, 2024 6 -$121K 4 Jul 17, 2024 Director
TERN Terns Pharmaceuticals, Inc. Jun 10, 2024 1 $0 4 Jun 14, 2024 Director
TERN Terns Pharmaceuticals, Inc. Jan 23, 2024 1 $0 4 Jan 25, 2024 Sr. Advisor & Strategy Officer, Director
TERN Terns Pharmaceuticals, Inc. Nov 15, 2023 1 $0 4 Nov 17, 2023 Sr. Advisor & Strategy Officer, Director
CMMB Chemomab Therapeutics Ltd. Jun 16, 2023 2 $0 4 Jun 20, 2023 Director
TERN Terns Pharmaceuticals, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
TERN Terns Pharmaceuticals, Inc. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
CMMB Chemomab Therapeutics Ltd. Jun 16, 2022 0 $0 3 Jun 21, 2022 Director
PASG Passage BIO, Inc. Dec 8, 2021 3 $16.6K 4 Dec 10, 2021 Chief Operating Officer
TERN Terns Pharmaceuticals, Inc. Sep 28, 2021 1 $0 4 Sep 30, 2021 Director